Evidence map›Paper›PMID 19423653›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2009

Dynamic in vivo binding of STAT5 to growth hormone-regulated genes in intact rat liver. Sex-specific binding at low- but not high-affinity STAT5 sites.

Ekaterina V Laz, Aarathi Sugathan, David J Waxman

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Regulation of gene expression by growth hormone.Molecular and cellular endocrinology · 2020
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Defining human insulin-like growth factor I gene regulation.American journal of physiology. Endocrinology and metabolism · 2016
    Article
  11. Article
  12. Article
  13. Article
  14. Minireview: mechanisms of growth hormone-mediated gene regulation.Molecular endocrinology (Baltimore, Md.) · 2014
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ekaterina V LazDivision of Cell and Molecular Biology, Department of Biology, Boston University, Boston, Massachusetts 02215, USA.
Aarathi Sugathan
David J Waxman
Boston University · US

Funding

Training CoreP42ES007381 · NIEHS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HAHN, MARK E · 1995 to 2019
$46.1M
Regulation of Sex Differences in Liver MetabolismR01DK033765 · NIDDK · DANA-FARBER CANCER INSTITUTE · PI WAXMAN, DAVID J · 1986 to 2017
$8.7M
Regulation of sex differences in liver metabolismR56DK033765 · NIDDK · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI WAXMAN, DAVID J · 2018 to 2018
$206k
NIDDK NIH HHS DK33765NIDDK NIH HHS R01 DK033765NIDDK NIH HHS R56 DK033765NIEHS NIH HHS 5 P42 ES07381NIEHS NIH HHS P42 ES007381
6 · The paper itself

Abstract

Phylogenetic footprinting was used to predict functional transcription factor binding sites (TFBS) for signal transducer and activator of transcription (STAT) 5, a GH-activated transcription factor, in the GH-responsive genes IGF-I, SOCS2, and HNF6. Each gene, including upstream (100 kb) and downstream regions (25 kb), was aligned across four species and searched for conserved STAT5-binding sites using TFBS matrices. Predicted sites were classified as paired or single and whether or not they matched the STAT5 consensus sequence TTCN(3)GAA. Fifty-seven of the predicted genomic regions were assayed by chromatin immunoprecipitation from male rat liver with high STAT5 activity. STAT5 binding was enriched (up to 24-fold) at eight genomic regions of IGF-I, including three novel regions in the second intron, and at four regions of SOCS2, including three novel upstream sites. STAT5 binding to HNF6 was modestly enriched (up to 3-fold) at one consensus site and two novel, nonconsensus sites. Overall, 14 of 17 identified sites were paired STAT5 sites. STAT5 binding to these sites was dynamic in male rat liver, cycling on and off in response to each plasma GH pulse. Moreover, sex-specific STAT5 binding was apparent; in female rat liver, where nuclear STAT5 activity is generally low, STAT5 binding to IGF-I and SOCS2 was limited to high-affinity sites. Analysis of the verified STAT5 binding sites indicated that STAT5 TFBS matrix 459 in combination with a STAT5 consensus sequence was the best predictor of STAT5 binding to these three genes. Using these criteria, multiple novel STAT5 binding sites were identified and then verified in several other GH-inducible genes, including MUP genes, where male-specific gene expression was associated with male-specific STAT5 binding to multiple low-affinity STAT5 sites.

Indexed as

AnimalsBinding SitesCell LineDNAGrowth HormoneHepatocyte Nuclear Factor 6HumansInsulin-Like Growth Factor IKineticsLiverMaleProtein BindingRatsSTAT5 Transcription FactorSuppressor of Cytokine Signaling ProteinsDNAGrowth HormoneHepatocyte Nuclear Factor 6Insulin-Like Growth Factor IOnecut1 protein, ratSocs2 protein, ratSTAT5 Transcription FactorSuppressor of Cytokine Signaling Proteins

Identifiers

PMID19423653
PMCPMC2718744
OpenAlexW2074922468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.